Time to Clarify Common Misconceptions about the Liver Imaging Reporting and Data System for Contrast-enhanced US-Reference-Cited by-同舟云学术

Time to Clarify Common Misconceptions about the Liver Imaging Reporting and Data System for Contrast-enhanced US

Published:2020-04 Issue:1 Volume:295 Page:245-247
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Kono Yuko¹^ORCID,Sirlin Claude B.¹^ORCID,Fetzer David T.²^ORCID,Kim Tae K.³^ORCID,Rodgers Shuchi K.⁴^ORCID,Piscaglia Fabio⁵^ORCID,Lyshchik Andrej⁶^ORCID,Dietrich Christoph F.⁷^ORCID,Wilson Stephanie R.⁸^ORCID

Affiliation:

1. Department of Medicine, Department of Radiology, University of California, San Diego, 200 W Arbor Dr, San Diego, CA 92103

2. Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Tex

3. Department of Medical Imaging, University Health Network, University of Toronto, Toronto, Canada

4. Department of Radiology, Einstein Medical Center, Philadelphia, Pa

5. Division of Internal Medicine, University and General Hospital S. Orsola-Malpighi, University of Bologna, Bologna, Italyǁ

6. Department of Radiology, Thomas Jefferson University, Philadelphia, Pa

7. Department of Internal Medicine 2, Caritas Krankenhaus, Bad Mergentheim, Germany

8. Department of Radiology, University of Calgary, Calgary, Canada††

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.2020192557

Reference13 articles.

1. State of the Art: LI-RADS for Contrast-enhanced US

2. Contrast-Enhanced Ultrasound for the Characterization of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

3. CEUS in Hepatocellular Carcinoma and Intrahepatic Cholangiocellular Carcinoma in 320 Patients – Early or Late Washout Matters: A Subanalysis of the DEGUM Multicenter Trial

4. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

5. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CEUS LI-RADS in Combination With the Serum Biomarker-Based ASAP Model Improves the Diagnostic Performance of HCC in High-Risk Patients;Ultrasound in Medicine & Biology;2024-08

2. Meld-sarcopenia score and skeletal muscle density predicts short-term readmission of patients with hepatic encephalopathy;European Journal of Radiology;2023-12

3. Performance of current versus modified CEUS LI-RADS in the diagnosis of non-hepatocellular carcinoma malignancies;Abdominal Radiology;2023-09-19

4. Focal liver lesions other than hepatocellular carcinoma in cirrhosis: Diagnostic challenges;Journal of Translational Internal Medicine;2022-12-01

5. Diagnostic value of CEUS LI-RADS and serum tumor markers for combined hepatocellular-cholangiocarcinoma;European Journal of Radiology;2022-09